Login / Signup

Direct detection of early-stage cancers using circulating tumor DNA.

Jillian A PhallenMark SausenVilmos AdleffAlessandro LealCarolyn HrubanJames WhiteValsamo AnagnostouJacob FikselStephen CristianoEniko PappSavannah SpeirThomas ReinertMai-Britt Worm OrntoftBrian D WoodwardDerek MurphySonya Parpart-LiDavid RileyMonica NesselbushNaomi SengamalayAndrew GeorgiadisQing Kay LiMogens Rørbæk MadsenFrank Viborg MortensenJoost HuiskensCornelis J A PuntNicole C T van GriekenRemond J A FijnemanGerrit MeijerHatim HusainRobert B ScharpfLuis A DiazSiân JonesSamuel V AngiuoliMai-Britt Worm ØrntoftHans Jørgen NielsenClaus Lindbjerg AndersenVictor E Velculescu
Published in: Science translational medicine (2018)
Early detection and intervention are likely to be the most effective means for reducing morbidity and mortality of human cancer. However, development of methods for noninvasive detection of early-stage tumors has remained a challenge. We have developed an approach called targeted error correction sequencing (TEC-Seq) that allows ultrasensitive direct evaluation of sequence changes in circulating cell-free DNA using massively parallel sequencing. We have used this approach to examine 58 cancer-related genes encompassing 81 kb. Analysis of plasma from 44 healthy individuals identified genomic changes related to clonal hematopoiesis in 16% of asymptomatic individuals but no alterations in driver genes related to solid cancers. Evaluation of 200 patients with colorectal, breast, lung, or ovarian cancer detected somatic mutations in the plasma of 71, 59, 59, and 68%, respectively, of patients with stage I or II disease. Analyses of mutations in the circulation revealed high concordance with alterations in the tumors of these patients. In patients with resectable colorectal cancers, higher amounts of preoperative circulating tumor DNA were associated with disease recurrence and decreased overall survival. These analyses provide a broadly applicable approach for noninvasive detection of early-stage tumors that may be useful for screening and management of patients with cancer.
Keyphrases